The new therapeutic modalities and associated manufacturing processes and technologies require a new workforce skillset. Process automation, process intensification, continuous manufacturing, and scale-out versus scale-up are examples of what are becoming new norms in manufacturing. The demand for a trained workforce is challenging many biopharma companies. This session will discuss approaches for meeting these challenges.
Vice Provost, Academic Affairs,
University of Maryland, Baltimore County